INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Conditions:   Advanced Malignancies;   Metastatic Malignancies
Interventions:   Drug: INCAGN01876;   Drug: Epacadostat;   Drug: Pembrolizumab
Sponsor:   Incyte Biosciences International Sàrl
Not yet recruiting - verified August 2017

http://ift.tt/2wRIJ4y